As of 2025-10-22, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 137.56 USD. This relative valuation is based on P/E multiples. With the latest stock price at 137.50 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 130.41 - 159.58 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 26.6x - 32.6x | 28.1x |
| Fair Price | 130.41 - 159.58 | 137.56 |
| Upside | -5.2% - 16.1% | 0.0% |
| Date | P/E |